SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000909567-03-000717
Filing Date
2003-05-27
Accepted
2003-05-27 12:42:28
Documents
4
Period of Report
2003-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K t09992e6vk.txt 6-K 1975
3 FIRST QUARTER REPORT (JUNE 1, 2002 - AUG 31, 2002) t09992exv99w1.txt EX-99.1 24868
4 SECOND QUARTER REPORT (SEPT 1, 2002 -NOV 31, 2002) t09992exv99w2.txt EX-99.2 28322
5 THIRD QUARTER REPORT (DEC 1, 2002 - FEB 28, 2003) t09992exv99w3.txt EX-99.3 28184
  Complete submission text file 0000909567-03-000717.txt   85578
Mailing Address 2 MERIDIAN ROAD TORONTO ONTARIO M9W A6 0000
Business Address 1285 MORNINGSIDE AVE SCARBOROUGH ONTARIO M1B 3W2 CANADA M1B 3W2 A6 M3B 1Y8
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 000-19763 | Film No.: 03719491
SIC: 2836 Biological Products, (No Diagnostic Substances)